Business● Low6d ago · Nov 4, 2026, 5:36 AM
Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Pfizer has increased its financial outlook for 2026, projecting revenues between $62 billion and $64 billion and adjusted earnings per share of $2.95 to $3.05. The company also aims for a high single-digit compound annual growth rate for revenue from 2028 to 2033.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business29m agoPrecipio outlines 2027 exit run-rate targets exceeding $40M, led by products above $10MSeeking Alpha TechBusiness30m agoQumulusAI reaffirms 18 megawatts year-end contracted capacity target while guiding to $300M year-end forward ARRSeeking Alpha TechBusiness31m agoDiscussed piece of furniture: Amthor beach chair: Tenfold click rate, but no sales increaseDie Zeit · GermanyBusiness33m agoMelbourne Uni cuts 179 staff as it bleeds cash for fifth year in a rowSydney Morning Herald · Australia